European academy of neurology/Movement Disorder Society‐European section guideline on the treatment of Parkinson's disease: I. Invasive therapies

G Deuschl, A Antonini, J Costa… - European Journal of …, 2022 - Wiley Online Library
Abstract Background and Purpose This update of the treatment guidelines was
commissioned by the European Academy of Neurology and the European section of the …

Deep brain stimulation in movement disorders: from experimental surgery to evidence‐based therapy

P Krack, J Volkmann, G Tinkhauser… - Movement …, 2019 - Wiley Online Library
Deep brain stimulation (DBS) of 3 different targets is the most important therapeutic
innovation of the past 30 years for patients with fluctuating Parkinson's disease (PD) …

Non-motor outcomes depend on location of neurostimulation in Parkinson's disease

JN Petry-Schmelzer, M Krause, TA Dembek, A Horn… - Brain, 2019 - academic.oup.com
Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for
patients with advanced Parkinson's disease improving quality of life, motor symptoms and …

Deep brain stimulation selection criteria for Parkinson's disease: time to go beyond CAPSIT-PD

CA Artusi, L Lopiano, F Morgante - Journal of clinical medicine, 2020 - mdpi.com
Despite being introduced in clinical practice more than 20 years ago, selection criteria for
deep brain stimulation (DBS) in Parkinson's disease (PD) rely on a document published in …

Neurostimulation for advanced parkinson disease and quality of life at 5 years: a nonrandomized controlled trial

ST Jost, S Aloui, J Evans, K Ashkan… - JAMA network …, 2024 - jamanetwork.com
Importance Deep brain stimulation of the subthalamic nucleus (STN-DBS) improves quality
of life (QOL) in patients with advanced Parkinson disease (PD). However, controlled studies …

Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease

W Xu, J Wang, XN Li, J Liang, L Song, Y Wu… - Translational …, 2023 - Springer
Deep brain stimulation (DBS) is a well-established and effective treatment for patients with
advanced Parkinson's disease (PD), yet its underlying mechanisms remain enigmatic …

The role of levodopa challenge in predicting the outcome of subthalamic deep brain stimulation

R Wolke, JS Becktepe, S Paschen… - Movement disorders …, 2023 - Wiley Online Library
Background Deep brain stimulation of the subthalamic nucleus (STN‐DBS) is an effective
and evidence‐based treatment for idiopathic Parkinson's disease (iPD). A minority of …

Changing gears–DBS for dopaminergic desensitization in Parkinson's disease?

D Weiss, J Volkmann, A Fasano, A Kühn… - Annals of …, 2021 - Wiley Online Library
In Parkinson's disease, both motor and neuropsychiatric complications unfold as a
consequence of both incremental striatal dopaminergic denervation and intensifying long …

Personalised advanced therapies in Parkinson's disease: the role of non-motor symptoms profile

V Leta, HS Dafsari, A Sauerbier, V Metta… - Journal of personalized …, 2021 - mdpi.com
Device-aided therapies, including levodopa-carbidopa intestinal gel infusion, apomorphine
subcutaneous infusion, and deep brain stimulation, are available in many countries for the …

[HTML][HTML] Clinical trials for deep brain stimulation: current state of affairs

IE Harmsen, GJB Elias, ME Beyn, A Boutet, A Pancholi… - Brain stimulation, 2020 - Elsevier
Background Deep brain stimulation (DBS) is a surgical neuromodulation procedure with a
historically wide range of possible therapeutic indications, including movement disorders …